CIMAP3
Ciliary microtubule-associated protein 3
Also known as: C1orf88, CMAP3_HUMAN, FLJ23853, PIFO, pitchfork
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCI5
- Gene
- CIMAP3
- Ensembl
- ENSG00000173947
- Chromosome
- 1
- Canonical length
- 191 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables cytoskeletal protein binding activity and enzyme binding activity. Involved in positive regulation of kinase activity. Predicted to be located in ciliary basal body and trans-Golgi network. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
191 residues, UniProt reviewed canonical sequence.
>Q8TCI5|CIMAP3
1 MCFSRADAAD NYPFGTCQQR KLFPHFHPPN LIGNKFVPLR GSPHRGPGCY FSDGYGLAYD
61 LSKIPTSIKG YTLGARTAVR FKPIQKEMTP HAGRYQKVSP QQEKHKQNFA PFNVLVPRFK
121 NYPKDTYYPS PGAYNPEKKP PPKIAWPMKF GSPDWAQVPC LQKRTLKAEL STDKDFRKHR
181 NRVAYLSLYY NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIMAP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 164 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 164 nTPM
- choroid plexus: 134 nTPM
- testis: 23 nTPM
- parathyroid gland: 14 nTPM
- thyroid gland: 14 nTPM
- hypothalamus: 13 nTPM
Single-cell type
- fallopian tube ciliated cells: 1,265 nCPM
- respiratory ciliated cells: 949 nCPM
- epididymal efferent duct ciliated cells: 682 nCPM
- late spermatids: 642 nCPM
- endometrial ciliated cells: 542 nCPM
- early spermatids: 495 nCPM
Immune cell
- MAIT T-cell: 0.7 nTPM
- memory B-cell: 0.4 nTPM
- naive CD4 T-cell: 0.4 nTPM
- memory CD4 T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
Brain region
- choroid plexus: 66 nTPM
- midbrain: 22 nTPM
- medulla oblongata: 21 nTPM
- white matter: 18 nTPM
- spinal cord: 15 nTPM
- hypothalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium organization
- embryonic heart tube left/right pattern formation
- positive regulation of kinase activity
- regulation of cell projection organization
Molecular functions
- beta-tubulin binding
- cytoskeletal protein binding
- gamma-tubulin binding
- kinesin binding
- protein kinase binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sperm-tail PG-rich repeat
- Sperm-tail PG-rich repeat
- Ciliary microtubule-associated protein 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CIMAP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIMAP3 as an antibody target. Whether an autoantibody or antibody against CIMAP3 could matter depends on whether native CIMAP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIMAP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIMAP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...